Stephen Amdur is a partner in the New York office of Latham & Watkins and a member of the Corporate Department.
Mr. Amdur has a broad-based practice, representing public and private companies, including private equity and venture capital investment funds, in connection with mergers and acquisitions, public and private financing, tender offers, joint ventures and other general corporate matters. He has represented numerous public companies, private equity firms and financial advisors in transactions involving US and foreign companies across a wide range of industries, including financial services, life sciences, media, sports, retail, chemicals, energy, telecommunications and manufacturing.
Mr. Amdur is also an active participant in the firm’s pro bono program, having served as global coordinator of the firm’s Veterans Pro Bono project and as a local coordinator of the firm’s representation of Holocaust survivors seeking reparations through the German Ghetto Work Payment Program.
Mr. Amdur has been recognized in the 2013 and 2014 issues of New York Super Lawyers as a "Rising Star" in the area of Mergers & Acquisitions. He is also recommended by The Legal 500 US 2014. Additionally Mr. Amdur is also a Term Member of the Council on Foreign Relations.
Mr. Amdur's representative matters include:
- Actavis plc in numerous matters, including the US$25 billion acquisition of Forest Laboratories, the US$8.5 billion acquisition of Warner Chilcott plc and the US$5.65 billion acquisition of Actavis Group by the former Watson Pharmaceuticals
- Leonard Green & Partners in numerous matters, including the US$3 billion acquisition, along with TPG Capital, of J. Crew, the US$1.6 billion acquisition of Jo-Ann Stores and the US$225 million acquisition of Lucky Brand Jeans
- KKR & Co., L.P. in numerous matters, including the US$2.4 billion acquisition of Sedgwick, the acquisition of Alliant Insurance Services from The Blackstone Group and the acquisition of Internet Brands from Hellman & Friedman and JMI Equity
- Odyssey Investment Partners in numerous matters, including the acquisition of Pexco LLC and the US$496 million sale of Pexco Aerospace to TransDigm Group Incorporated
- Simeio Solutions in its strategic partnership with Welsh, Carson, Anderson & Stowe
- The Raine Group in numerous matters, including its growth equity investment in DraftKings
- Cartesian Capital in numerous matters, including with respect to its investments in GrupoTorreSur and Network Management Services
- Alliant Insurance Services in numerous matters, including the acquisition of the US Agencies business from QBE
- Navig8 Crude Tankers Inc. in its US$3 billion stock-for-stock merger with General Maritime Corporation
- Global Crossing in its US$3 billion stock for stock merger with Level 3
- E-Land Group in the attempted acquisition of the Los Angeles Dodgers
- Goldman Sachs & Co. as financial advisor to The Anheuser-Busch Companies, Inc. in its US$52 billion acquisition by InBev S.A.
- AlpInvest Partners, The Blackstone Group, The Carlyle Group, Hellman & Friedman, Kohlberg Kravis Roberts & Co. and Thomas H. Lee Partners in the €8.7 billion acquisition of VNU NV
- Macquarie Infrastructure Partners in the US$7.2 billion acquisition of Puget Energy by a consortium led by Macquarie Infrastructure Partners
- Ares Capital Corporation in the acquisitions of the Senior Secured Loan Fund and the Allied Capital Senior Debt Fund from Allied Capital
- Sabre Holdings in the US$5 billion take private sale to Texas Pacific Group and Silver Lake Partners
- Adecco SA in numerous matters, including the US$1.289 billion acquisition of MPS Group, Inc. and acquisition of Drake Beam Morin from Compass Partners
- JP Morgan Securities as financial advisor to Olin in its US$5 billion Reverse Morris Trust combination with the chlorine business of Dow Chemical, to Exelis in its $4.75 billion merger with Harris Corporation, Merck in its US$9.5 billion acquisition of Cubist, Wright Medical Group in its US$3.3 billion merger with Tornier, MAKO Surgical Corp. in its US$1.65 billion acquisition by Stryker Corporation and to Pfizer in connection with its US$3.6 billion acquisition of King Pharmaceuticals
- CCMP Capital Advisors, LLC and PQ Corporation in the US$1.515 billion sale of Niagara Holdings and PQ Corporation to The Carlyle Group
- Société Générale in the minority equity investment in Rockefeller Financial Services and formation of a global alliance with its subsidiary, Rockefeller & Co., Inc.